Amy S. Fisher
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain, volume II.
Journal: Frontiers in pharmacology
Published: April 30, 2024
Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs.
Journal: Frontiers in psychology
Published: January 12, 2024
Experiences of moving an older parent into a care home or nursing home in the UK: a qualitative study.
Journal: Current psychology (New Brunswick, N.J.)
Published: March 10, 2023
Editorial: Exploring neuroinflammatory pathways that contribute to chronic pain.
Journal: Frontiers in pharmacology
Published: August 22, 2022
Evaluation of Recombinant Botulinum Neurotoxin Type A1 Efficacy in Peripheral Inflammatory Pain in Mice.
Journal: Frontiers in molecular neuroscience
Published: March 31, 2022
Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research.
Journal: Frontiers in pharmacology
Published: October 07, 2020
Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.
Exenatide Improves Bone Quality in a Murine Model of Genetically Inherited Type 2 Diabetes Mellitus.
Journal: Frontiers in endocrinology
Published: August 09, 2017
Development and initial validation of a sensory threshold examination protocol (STEP) for phenotyping canine pain syndromes.
Journal: Veterinary anaesthesia and analgesia
Published: February 22, 2016
Neurokinin-1 receptor antagonist orvepitant is an effective inhibitor of itch-associated response in a Mongolian gerbil model of scratching behaviour.
Journal: Experimental dermatology
Published: July 24, 2014
Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.
Journal: Synapse (New York, N.Y.)
Published: December 12, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026